ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,110.05
      -0.12%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV
      6. Novo Nordisk (N1VO34)

      7. Novo Nordisk (N1VO34) Financials

      N1VO34 Novo Nordisk

      95.34
      -0.47 (-0.49%)
      Jun 14 2024 - Closed
      Delayed by 15 minutes

      Novo Nordisk Financial Summary

      The current N1VO34 market cap is 3.27T. The company's latest EPS is DKK 2.4362 and P/E is 58.28.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 53.37B54.3B58.73B65.86B65.35B
      Operating Income 25.01B23.89B26.91B26.85B31.85B
      Net Income 19.81B19.43B22.48B21.96B25.41B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 122.02B126.95B140.8B176.95B232.26B
      Operating Income 52.35B54.28B58.62B74.62B102.66B
      Net Income 38.95B42.14B47.76B55.53B83.68B

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 250.03B280.75B300.1B314.49B298.92B
      Total Liabilities 170.15B190.28B207.11B207.93B200.01B
      Total Equity 79.87B90.47B92.99B106.56B98.91B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 125.61B144.92B194.51B241.26B314.49B
      Total Liabilities 68.02B81.6B123.76B157.77B207.93B
      Total Equity 57.59B63.33B70.75B83.49B106.56B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 29.81B58.39B99.36B108.91B14.31B
      Investing -6.65B-15.93B-29.18B-43.89B3.96B
      Financing -20.62B-33.21B-53.04B-63.16B-26.38B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 46.78B51.95B55B78.89B108.91B
      Investing -11.51B-22.44B-31.61B-24.92B-43.89B
      Financing -35.48B-32.24B-25.49B-51.8B-63.16B

      Stats and Ratios

      Market Cap 3.27T
      Price to Earnings Ratio 58.28
      Price to Sales Ratio 21
      Price to Cash Ratio 338.85
      Price to Book Ratio 45.77
      Dividend Yield 0.68%

      Share Statistics

      Shares Outstanding 34.35B
      Average Volume (1 week) 9.81k
      Average Volume (1 Month) 9.2k
      52 Week Change 96.54%
      52 Week High 102.61
      52 Week Low 45.59
      Spread (Intraday) 2.11 (2.17%)

      Company Info

      Company Name Novo Nordisk
      Address novo alle
      bagsvaerd DK-2880
      Website https://www.novonordisk.com
      Industry pharmaceutical preparations (2834)